HomeSTABL • STO
add
Stayble Therapeutics AB
Previous close
kr 0.21
Day range
kr 0.19 - kr 0.22
Year range
kr 0.15 - kr 0.70
Market cap
13.97M SEK
Avg Volume
349.29K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
MarketBeat
18 minutes ago
Telix Pharmaceuticals (NASDAQ:TLX) Sees Strong Trading Volume - Time to Buy?
1.01%
2.86%
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.48M | -37.11% |
Net income | -1.48M | 36.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.80M | — |
Total assets | 9.90M | — |
Total liabilities | 1.44M | — |
Total equity | 8.46M | — |
Shares outstanding | 64.36M | — |
Price to book | 1.62 | — |
Return on assets | -33.58% | — |
Return on capital | -36.90% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.48M | 36.53% |
Cash from operations | -1.85M | 58.60% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.85M | 58.62% |
Free cash flow | -1.29M | — |
About
Founded
2015
Website
Employees
2
